227 related articles for article (PubMed ID: 23898841)
21. A Phenotypic Based Target Screening Approach Delivers New Antitubercular CTP Synthetase Inhibitors.
Esposito M; Szadocka S; Degiacomi G; Orena BS; Mori G; Piano V; Boldrin F; Zemanová J; Huszár S; Barros D; Ekins S; Lelièvre J; Manganelli R; Mattevi A; Pasca MR; Riccardi G; Ballell L; Mikušová K; Chiarelli LR
ACS Infect Dis; 2017 Jun; 3(6):428-437. PubMed ID: 28475832
[TBL] [Abstract][Full Text] [Related]
22. Nitazoxanide kills replicating and nonreplicating Mycobacterium tuberculosis and evades resistance.
de Carvalho LP; Lin G; Jiang X; Nathan C
J Med Chem; 2009 Oct; 52(19):5789-92. PubMed ID: 19736929
[TBL] [Abstract][Full Text] [Related]
23. Baeyer-Villiger Monooxygenases EthA and MymA Are Required for Activation of Replicating and Non-replicating Mycobacterium tuberculosis Inhibitors.
Grant SS; Wellington S; Kawate T; Desjardins CA; Silvis MR; Wivagg C; Thompson M; Gordon K; Kazyanskaya E; Nietupski R; Haseley N; Iwase N; Earl AM; Fitzgerald M; Hung DT
Cell Chem Biol; 2016 Jun; 23(6):666-77. PubMed ID: 27321573
[TBL] [Abstract][Full Text] [Related]
24. Screening of antitubercular compound library identifies novel ATP synthase inhibitors of Mycobacterium tuberculosis.
Kumar S; Mehra R; Sharma S; Bokolia NP; Raina D; Nargotra A; Singh PP; Khan IA
Tuberculosis (Edinb); 2018 Jan; 108():56-63. PubMed ID: 29523328
[TBL] [Abstract][Full Text] [Related]
25. Effect of Moxifloxacin plus Pretomanid against
de Miranda Silva C; Hajihosseini A; Myrick J; Nole J; Louie A; Schmidt S; Drusano GL
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30397058
[TBL] [Abstract][Full Text] [Related]
26. Copper-boosting compounds: a novel concept for antimycobacterial drug discovery.
Speer A; Shrestha TB; Bossmann SH; Basaraba RJ; Harber GJ; Michalek SM; Niederweis M; Kutsch O; Wolschendorf F
Antimicrob Agents Chemother; 2013 Feb; 57(2):1089-91. PubMed ID: 23254420
[TBL] [Abstract][Full Text] [Related]
27. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
[TBL] [Abstract][Full Text] [Related]
28. Development of 3,5-Dinitrobenzylsulfanyl-1,3,4-oxadiazoles and Thiadiazoles as Selective Antitubercular Agents Active Against Replicating and Nonreplicating Mycobacterium tuberculosis.
Karabanovich G; Zemanová J; Smutný T; Székely R; Šarkan M; Centárová I; Vocat A; Pávková I; Čonka P; Němeček J; Stolaříková J; Vejsová M; Vávrová K; Klimešová V; Hrabálek A; Pávek P; Cole ST; Mikušová K; Roh J
J Med Chem; 2016 Mar; 59(6):2362-80. PubMed ID: 26948407
[TBL] [Abstract][Full Text] [Related]
29. Oxadiazoles Have Butyrate-Specific Conditional Activity against Mycobacterium tuberculosis.
Early JV; Casey A; Martinez-Grau MA; Gonzalez Valcarcel IC; Vieth M; Ollinger J; Bailey MA; Alling T; Files M; Ovechkina Y; Parish T
Antimicrob Agents Chemother; 2016 Jun; 60(6):3608-16. PubMed ID: 27044545
[TBL] [Abstract][Full Text] [Related]
30. Identification of 2-Amino Benzothiazoles with Bactericidal Activity against Mycobacterium tuberculosis.
Bonnett S; Jee JA; Chettiar S; Ovechkina Y; Korkegian A; Greve E; Odingo J; Parish T
Microbiol Spectr; 2023 Feb; 11(1):e0497422. PubMed ID: 36688635
[TBL] [Abstract][Full Text] [Related]
31. NU-6027 Inhibits Growth of Mycobacterium tuberculosis by Targeting Protein Kinase D and Protein Kinase G.
Kidwai S; Bouzeyen R; Chakraborti S; Khare N; Das S; Priya Gosain T; Behura A; Meena CL; Dhiman R; Essafi M; Bajaj A; Saini DK; Srinivasan N; Mahajan D; Singh R
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285226
[TBL] [Abstract][Full Text] [Related]
32. Bactericidal Disruption of Magnesium Metallostasis in Mycobacterium tuberculosis Is Counteracted by Mutations in the Metal Ion Transporter CorA.
Lopez Quezada L; Silve S; Kelinske M; Liba A; Diaz Gonzalez C; Kotev M; Goullieux L; Sans S; Roubert C; Lagrange S; Bacqué E; Couturier C; Pellet A; Blanc I; Ferron M; Debu F; Li K; Aubé J; Roberts J; Little D; Ling Y; Zhang J; Gold B; Nathan C
mBio; 2019 Jul; 10(4):. PubMed ID: 31289182
[TBL] [Abstract][Full Text] [Related]
33. New Insights into the Mechanism of Action of the Thienopyrimidine Antitubercular Prodrug TP053.
Chiarelli LR; Salina EG; Mori G; Azhikina T; Riabova O; Lepioshkin A; Grigorov A; Forbak M; Madacki J; Orena BS; Manfredi M; Gosetti F; Buzzi A; Degiacomi G; Sammartino JC; Marengo E; Korduláková J; Riccardi G; Mikušová K; Makarov V; Pasca MR
ACS Infect Dis; 2020 Feb; 6(2):313-323. PubMed ID: 31729215
[TBL] [Abstract][Full Text] [Related]
34. A New Benzothiazolthiazolidine Derivative, 11726172, Is Active
Salina EG; Postiglione U; Chiarelli LR; Recchia D; Záhorszká M; Lepioshkin A; Monakhova N; Pál A; Porta A; Zanoni G; Korduláková J; Kazakova E; Sassera D; Pasca MR; Makarov V; Degiacomi G
mSphere; 2022 Dec; 7(6):e0036922. PubMed ID: 36377880
[TBL] [Abstract][Full Text] [Related]
35. High-throughput screen identifies small molecule inhibitors targeting acetyltransferase activity of Mycobacterium tuberculosis GlmU.
Rani C; Mehra R; Sharma R; Chib R; Wazir P; Nargotra A; Khan IA
Tuberculosis (Edinb); 2015 Dec; 95(6):664-677. PubMed ID: 26318557
[TBL] [Abstract][Full Text] [Related]
36. Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.
Williams JT; Haiderer ER; Coulson GB; Conner KN; Ellsworth E; Chen C; Alvarez-Cabrera N; Li W; Jackson M; Dick T; Abramovitch RB
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405862
[TBL] [Abstract][Full Text] [Related]
37. Selective Killing of Dormant Mycobacterium tuberculosis by Marine Natural Products.
Rodrigues Felix C; Gupta R; Geden S; Roberts J; Winder P; Pomponi SA; Diaz MC; Reed JK; Wright AE; Rohde KH
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28607021
[TBL] [Abstract][Full Text] [Related]
38. Discovery and optimization of benzotriazine di-N-oxides targeting replicating and nonreplicating Mycobacterium tuberculosis.
Chopra S; Koolpe GA; Tambo-Ong AA; Matsuyama KN; Ryan KJ; Tran TB; Doppalapudi RS; Riccio ES; Iyer LV; Green CE; Wan B; Franzblau SG; Madrid PB
J Med Chem; 2012 Jul; 55(13):6047-60. PubMed ID: 22691154
[TBL] [Abstract][Full Text] [Related]
39. Mycobacterium tuberculosis High-Throughput Screening.
White EL; Tower NA; Rasmussen L
Methods Mol Biol; 2016; 1439():181-95. PubMed ID: 27316996
[TBL] [Abstract][Full Text] [Related]
40. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]